These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5059031)

  • 1. A correlation between cyclophosphamide induced leukopenia in mice and the presence of alkylating metabolites.
    Hayes FD; Short RD; Gibson JE
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):417-21. PubMed ID: 5059031
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice.
    Hart LG; Adamson RH
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):391-401. PubMed ID: 5348409
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of phenobarbital on cyclophosphamide metabolism in rats.
    Donelli MG; Guaitani A; Bartosek I; Bossi A; Colombo T; Garattini S
    Xenobiotica; 1976 Oct; 6(10):625-31. PubMed ID: 983118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dosage, phenobarbital, and 2-diethylaminoethyl-2,2-diphenylvalerate on the binding of cyclophosphamide and-or its metabolites to the DNA, RNA, and protein of the embryo and liver in pregnant mice.
    Murthy VV; Becker BA; Steele WJ
    Cancer Res; 1973 Apr; 33(4):664-70. PubMed ID: 4696467
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
    J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of phenobarbital and SKF 525A on the toxicity, elimination and metabolism of cyclophosphamide in newborn mice.
    Bus JS; Short RD; Gibson JE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):749-56. PubMed ID: 4687235
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice.
    Weber K; Mengs U; Schwarz T; Becker H; Lentzen H
    Arzneimittelforschung; 1996 Dec; 46(12):1174-8. PubMed ID: 9006795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of N-acetylcysteine on some aspects of cyclophosphamide-induced toxicity and immunosuppression.
    Levy L; Harris R
    Biochem Pharmacol; 1977 Jun; 26(11):1015-20. PubMed ID: 18149
    [No Abstract]   [Full Text] [Related]  

  • 9. Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
    DeConti RC; Kaplan SR; Calabresi P
    Blood; 1972 May; 39(5):602-9. PubMed ID: 5067305
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of phenobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice.
    Gibson JE; Becker BA
    Teratology; 1968 Nov; 1(4):393-8. PubMed ID: 4992685
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
    Allen LM; Creaven PJ
    Cancer Chemother Rep; 1972 Oct; 56(5):603-10. PubMed ID: 4405717
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of pretreatment with spironolactone, phenobarbital or -diethylaminoethyl diphenylpropylacetate (SKF 525-A) on tritium levels in blood, heart and liver of rats at various times after administration of ( 3 H)digitoxin.
    Castle MC; Lage GL
    Biochem Pharmacol; 1972 May; 21(10):1449-55. PubMed ID: 5029425
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of recombinant Ganoderma lucidum immunoregulatory protein on cyclophosphamide-induced leukopenia in mice.
    Zhou H; Sun F; Li H; Zhang S; Liu Z; Pei J; Liang C
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):426-33. PubMed ID: 23656432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the activation of cyclophosphamide to a mutagen by rat liver.
    Hales BF; Jain R
    Biochem Pharmacol; 1980 Feb; 29(2):256-9. PubMed ID: 6767482
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of phenobarbital on cyclophosphamide antitumor activity.
    Alberts DS; van Daalen Wetters T
    Cancer Res; 1976 Aug; 36(8):2785-9. PubMed ID: 1277188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proadifen-sensitive high affinity binding of 3H-alaproclate to liver membranes.
    Ross SB
    Pharmacol Toxicol; 1987 Nov; 61(5):282-7. PubMed ID: 3438220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.
    Lalka D; Jusko WJ; Bardos TJ
    J Pharm Sci; 1975 Feb; 64(2):230-5. PubMed ID: 236372
    [No Abstract]   [Full Text] [Related]  

  • 18. Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Guérin.
    Ladisch S; Poplack DG; Bull JM
    Cancer Res; 1978 Apr; 38(4):1049-51. PubMed ID: 639036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the molecular mass of tremella polysaccharides on accelerated recovery from cyclophosphamide-induced leucopenia in rats.
    Jiang RZ; Wang Y; Luo HM; Cheng YQ; Chen YH; Gao Y; Gao QP
    Molecules; 2012 Mar; 17(4):3609-17. PubMed ID: 22447024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide.
    Stekar J; Hilgard P; Klenner T
    Eur J Cancer; 1995; 31A(3):372-4. PubMed ID: 7786605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.